Gabelli Funds LLC Edwards Lifesciences Corp Transaction History

Gabelli Funds LLC

$12.3 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $3.66 Million - $4.24 Million	44,975 Added 37.02%	166,455 $15.7 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $631,210 - $718,335	8,500 Added 7.52%	121,480 $10.1 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $7.72 Million - $9.88 Million	112,980 New	112,980 $8.43 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $4.56 Million - $6.76 Million	52,700 Added 17.14%	360,117 $34.2 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $10,705 - $13,475	105 Added 0.03%	307,417 $36.2 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $8 Million - $9.82 Million	75,174 Added 32.38%	307,312 $39.8 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $5.25 Million - $6.26 Million	-51,000 Reduced 18.01%	232,138 $26.3 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $11.7 Million - $14.7 Million	139,979 Added 97.78%	283,138 $29.3 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $3.75 Million - $4.33 Million	-47,701 Reduced 24.99%	143,159 $12 Million
Q4 2020 Feb 05, 2021	BUY	$71.69 - $91.23 $13.7 Million - $17.4 Million	190,860 New	190,860 $17.4 Million
Q3 2020 Nov 06, 2020	SELL	$67.19 - $87.44 $12.5 Million - $16.2 Million	-185,700 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $7.12 Million - $9.53 Million	123,800 Added 200.0%	185,700 $12.8 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $3.24 Million - $5.01 Million	61,900 New	61,900 $11.7 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $8.82 Million - $10.1 Million	-123,000 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$61.55 - $75.43 $430,850 - $528,010	7,000 Added 6.03%	123,000 $27 Million
Q2 2019 Aug 02, 2019	SELL	$55.74 - $64.41 $1.12 Million - $1.29 Million	-20,100 Reduced 14.77%	116,000 $21.4 Million
Q1 2019 May 02, 2019	BUY	$47.89 - $64.05 $2.15 Million - $2.88 Million	44,900 Added 49.23%	136,100 $26 Million
Q4 2018 Jan 30, 2019	BUY	$46.41 - $56.94 $92,820 - $113,880	2,000 Added 2.24%	91,200 $14 Million
Q3 2018 Nov 02, 2018	BUY	$45.7 - $58.03 $347,320 - $441,028	7,600 Added 9.31%	89,200 $15.5 Million
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $186,780 - $225,720	4,400 Added 5.7%	81,600 $11.9 Million
Q1 2018 May 09, 2018	BUY	$37.19 - $47.45 $2.87 Million - $3.66 Million	77,200 New	77,200 $10.8 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account